1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Angiotensin I: new trials by email Literature Review of Angiotensin I trials Research Report on Angiotensin I
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension LJPC-501, Placebo - Catecholamine-resistant Hypotension (CRH), Distributive Shock | Phase 3 | Completed | La Jolla Pharmaceutical Company | 344 | 2015-03-01 | 2018-03-27 |
Sepsis (1)
La Jolla Pharmaceutical Company (1)
Australia (1) · Belgium (1) · Canada (1) · Finland (1) · France (1) · Germany (1) · New Zealand (1) · Switzerland (1) · United Kingdom (1) · United States (1)
George F Tidmarsh, MD, PhD (1)
PMID 26931475, PMID 28528561, PMID 30144016, PMID 32028998, PMID 32609011, PMID 37147690, PMID 38103056, PMID 38637829, PMID 39972379